← Leaderboards
Junya Tomida
University Of Tx Md Anderson Can Ctr
$1,151,217
Attributed
$1,151,217
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $544.7K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,151,217 · 3
By mechanism
R15$991,217 · 2
R03$160,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Junjie Chen$28,940,212
- Sadhan Majumder$10,510,614
- Guillermina Lozano$24,537,407
- Hui-Lin Pan$27,634,836
- Anil K Sood$29,572,737
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsMutationDna DamageDna RepairPathway InteractionsDna Repair PathwayRepairedMalignant NeoplasmsDouble Strand Break RepairResponseMutantPrognosticNonhomologous Dna End JoiningProstate Cancer Cell LineBenignMalignant Neoplasm Of ProstateMonitorGenesFunctional DisorderCancer TherapyImmunohistochemistryCastration Resistant Prostate CancerExcisionInhibitor/Antagonist
Grant awards (5)
Defining novel roles of the DNA repair factor REV7 in p53 signaling and regulation$544,712
R15 · FY2025 · CA · contact PI
Synergistic DNA repair genes and sensitivity to radiation therapy in prostate cancer$446,505
R15 · FY2021 · CA · contact PI
Loss of novel end joining factor with dysfunction of BRCA1 contributes to treatment resistance$75,349
R03 · FY2018 · CA · contact PI
Loss of novel end joining factor with dysfunction of BRCA1 contributes to treatment resistance$4,651
R03 · FY2018 · CA · contact PI
Loss of novel end joining factor with dysfunction of BRCA1 contributes to treatment resistance$80,000
R03 · FY2017 · CA · contact PI